Re Provexis Admission to AIM

Angle PLC
24 June 2005


FOR IMMEDIATE RELEASE                                               24 June 2005

                                   ANGLE plc
                           ('ANGLE' or the 'Company')

         First day of Dealings for venture company Provexis plc on AIM

ANGLE plc, the venture management and consulting company specialising in the
commercialisation of technology, is pleased to announce that its venture company
Provexis plc, the nutraceutical company which develops scientifically-proven,
proprietary, functional foods, supplements and medical foods, announces
commencement of trading today in its ordinary shares on AIM under the ticker
symbol: PSX.L.

At the placing price of 5.6p per ordinary share, Provexis raised £5.9 million of
equity through an institutional placing of £3.8 million (before expenses) and
the conversion of £2.1 million of loans. On Admission and at the issue price the
market capitalisation was approximately £14 million.  Following the Placing
ANGLE owns 24.8% of Provexis plc.


For further details please contact:

  ANGLE plc
  Andrew Newland, Chief Executive                      Tel: [phone]
  Dawson Buck, Deputy Chief Executive

  Buchanan Communications
  Richard Darby                                        Tel: [phone]
  Suzanne Brocks
  James Strong


Note to editors:

ANGLE plc

Founded in 1994, ANGLE is an international venture management and consulting
company focusing on the commercialisation of technology and the development of
technology-based industry. ANGLE creates, develops and advises technology
businesses on its own behalf and for its clients. ANGLE is listed on AIM
(AGL.L); further information can be found on www.ANGLEplc.com

Provexis plc

Provexis is a nutraceutical business founded in 2000 as a joint venture with the
Rowett Institute, a leading human nutrition research centre and ANGLE, and is 1
of the 8 venture companies developed under ANGLE's Progeny(R) programme to date.


                      This information is provided by RNS
            The company news service from the London Stock Exchange